Sex-dependent control of murine emotional-affective behaviour in health and colitis by peptide YY and neuropeptide y

British Journal of Pharmacology

Volumn 163, Issue 6, 2011, Pages 1302-1314

  Painsipp, Evelin ^a   Herzog, Herbert ^b   Sperk, Günther ^c   Holzer, Peter ^a  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

anxiety like behaviour; colitis; corticosterone; depression like behaviour; dextran sulphate sodium; elevated plus maze; forced swim test; myeloperoxidase; neuropeptide Y; peptide YY

Indexed keywords

CORTICOSTERONE; MYELOPEROXIDASE; NEUROPEPTIDE Y; PEPTIDE YY;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANXIETY; ARTICLE; COLITIS; CONTROLLED STUDY; DEPRESSION; DISEASE ASSOCIATION; DISEASE SEVERITY; EMOTIONALITY; FEMALE; GENOTYPE; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; KNOCKOUT MOUSE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN FUNCTION; SEX DIFFERENCE; WILD TYPE;

ANIMALS; ANXIETY; BEHAVIOR, ANIMAL; COLITIS; DEPRESSION; DEXTRAN SULFATE; FEMALE; GENE EXPRESSION REGULATION; MALE; MICE; MICE, KNOCKOUT; NEUROPEPTIDE Y; PEPTIDE YY; PEROXIDASE; SEX CHARACTERISTICS;

EID: 79959732665     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2011.01326.x     Document Type: Article

References (53)

1. Adrian TE, Savage AP, Bacarese-Hamilton AJ, Wolfe K, Besterman HS, Bloom SR, (1986). Peptide YY abnormalities in gastrointestinal diseases. Gastroenterology 90: 379-384. (Pubitemid 16136680)
2. Alexander SPH, Mathie A, Peters JA, (2009). Guide to receptors and channels (GRAC). 4th edn. Br J Pharmacol 158 (Suppl. 1): S1-S254.
3. Bannon AW, Seda J, Carmouche M, Francis JM, Norman MH, Karbon B, et al,. (2000). Behavioral characterization of neuropeptide Y knockout mice. Brain Res 868: 79-87. (Pubitemid 30332345)
4. Batterham RL, Cowley MA, Small CJ, Herzog H, Cohen MA, Dakin CL, et al,. (2002). Gut hormone PYY(3-36) physiologically inhibits food intake. Nature 418: 650-654.
5. Batterham RL, Heffron H, Kapoor S, Chivers JE, Chandarana K, Herzog H, et al,. (2006). Critical role for peptide YY in protein-mediated satiation and body-weight regulation. Cell Metab 4: 223-233. (Pubitemid 44307976)
6. Batterham RL, Ffytche DH, Rosenthal JM, Zelaya FO, Barker GJ, Withers DJ, et al,. (2007). PYY modulation of cortical and hypothalamic brain areas predicts feeding behaviour in humans. Nature 450: 106-109. (Pubitemid 350070563)
7. Beery AK, Zucker I, (2011). Sex bias in neuroscience and biomedical research. Neurosci Biobehav Rev 35: 565-572.
8. Belzung C, Griebel G, (2001). Measuring normal and pathological anxiety-like behaviour in mice: a review. Behav Brain Res 125: 141-149. (Pubitemid 33000452)
9. Boey D, Lin S, Karl T, Baldock P, Lee N, Enriquez R, et al,. (2006). Peptide YY ablation in mice leads to the development of hyperinsulinaemia and obesity. Diabetologia 49: 1360-1370.
10. Chandrasekharan B, Bala V, Kolachala VL, Vijay-Kumar M, Jones D, Gewirtz AT, et al,. (2008). Targeted deletion of neuropeptide Y (NPY) modulates experimental colitis. PLoS One 3: e3304.
11. Cryan JF, Mombereau C, (2004). In search of a depressed mouse: utility of models for studying depression-related behavior in genetically modified mice. Mol Psychiatry 9: 326-357. (Pubitemid 38534696)
12. Cryan JF, Valentino RJ, Lucki I, (2005). Assessing substrates underlying the behavioral effects of antidepressants using the modified rat forced swimming test. Neurosci Biobehav Rev 29: 547-569. (Pubitemid 40755456)
13. Detke MJ, Rickels M, Lucki I, (1995). Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology (Berlin) 21: 66-72.
14. Domschke K, Dannlowski U, Hohoff C, Ohrmann P, Bauer J, Kugel H, et al,. (2010). Neuropeptide Y (NPY) gene: impact on emotional processing and treatment response in anxious depression. Eur Neuropsychopharmacol 20: 301-309.
15. Edelsbrunner ME, Herzog H, Holzer P, (2009). Evidence from knockout mice that peptide YY and neuropeptide Y enforce murine locomotion, exploration and ingestive behaviour in a circadian cycle- and gender-dependent manner. Behav Brain Res 203: 97-107.
16. El-Salhy M, Danielsson A, Stenling R, Grimelius L, (1997). Colonic endocrine cells in inflammatory bowel disease. J Intern Med 242: 413-419. (Pubitemid 27513108)
17. Eva C, Serra M, Mele P, Panzica G, Oberto A, (2006). Physiology and gene regulation of the brain NPY Y1 receptor. Front Neuroendocrinol 27: 308-339. (Pubitemid 44548041)
18. Fluttert M, Dalm S, Oitzl MS, (2000). A refined method for sequential blood sampling by tail incision in rats. Lab Anim 34: 372-378.
19. Gehlert DR, Shaw JL, (2007). Increased brain neuropeptide Y1 and Y2 receptor binding in NPY knock out mice does not result in increased receptor function. Peptides 28: 241-249. (Pubitemid 46188366)
20. Goehler LE, Park SM, Opitz N, Lyte M, Gaykema RPA, (2008). Campylobacter jejuni infection increases anxiety-like behavior in the holeboard: possible anatomical substrates for viscerosensory modulation of exploratory behavior. Brain Behav Immun 22: 354-366. (Pubitemid 351172701)
21. Gorman JM, (2006). Gender differences in depression and response to psychotropic medication. Gender Med 3: 93-109. (Pubitemid 44057819)
22. Hassani H, Lucas G, Rozell B, Ernfors P, (2005). Attenuation of acute experimental colitis by preventing NPY Y1 receptor signaling. Am J Physiol 288: G550-G556. (Pubitemid 40261755)
23. Heilig M, (2004). The NPY system in stress, anxiety and depression. Neuropeptides 38: 213-224. (Pubitemid 39158860)
24. Hirotani Y, Mikajiri K, Ikeda K, Myotoku M, Kurokawa N, (2008). Changes of the peptide YY levels in the intestinal tissue of rats with experimental colitis following oral administration of mesalazine and prednisolone. Yakugaku Zasshi 128: 1347-1353.
25. Iwai T, Hayashi Y, Narita S, Kasuya Y, Jin K, Tsugane M, et al,. (2009). Antidepressant-like effects of glucagon-like peptide-2 in mice occur via monoamine pathways. Behav Brain Res 204: 235-240.
26. Karl T, Burne TH, Herzog H, (2006). Effect of Y1 receptor deficiency on motor activity, exploration, and anxiety. Behav Brain Res 167: 87-93. (Pubitemid 43063142)
27. Karl T, Duffy L, Herzog H, (2008). Behavioural profile of a new mouse model for NPY deficiency. Eur J Neurosci 28: 173-180.
28. Kinzig KP, D'Alessio DA, Herman JP, Sakai RR, Vahl TP, Figueiredo HF, et al,. (2003). CNS glucagon-like peptide-1 receptors mediate endocrine and anxiety responses to interoceptive and psychogenic stressors. J Neurosci 23: 6163-6170. (Pubitemid 36875615)
29. Kirk RE, (1995). Experimental Design. Procedures for the Behavioral Sciences, 3rd edn. Wadsworth: Belmont, CA.
30. Klompus M, Ho W, Sharkey KA, McKay DM, (2010). Antisecretory effects of neuropeptide Y in the mouse colon are region-specific and are lost in DSS-induced colitis. Regul Pept 165: 138-145.
31. Krawisz JE, Sharon P, Stenson WF, (1984). Quantitative assay for acute intestinal inflammation based on myeloperoxidase activity. Assessment of inflammation in rat and hamster models. Gastroenterology 87: 1344-1350. (Pubitemid 15201434)
32. Lesch KP, Selch S, Renner TJ, Jacob C, Nguyen TT, Hahn T, et al,. (2010). Genome-wide copy number variation analysis in attention-deficit/hyperactivity disorder: association with neuropeptide Y gene dosage in an extended pedigree. Mol Psychiatry doi:10.1038/mp.2010.29.
33. Lin S, Boey D, Herzog H, (2004). NPY and Y receptors: lessons from transgenic and knockout models. Neuropeptides 38: 189-200. (Pubitemid 39161911)
34. Lutter M, Sakata I, Osborne-Lawrence S, Rovinsky SA, Anderson JG, Jung S, et al,. (2008). The orexigenic hormone ghrelin defends against depressive symptoms of chronic stress. Nat Neurosci 11: 752-753. (Pubitemid 351896679)
35. McGowan BMC, Bloom SR, (2004). Peptide YY and appetite control. Curr Opin Pharmacol 4: 583-588. (Pubitemid 40267873)
36. Mitrovic M, Shahbazian A, Bock E, Pabst MA, Holzer P, (2010). Chemo-nociceptive signalling from the colon is enhanced by mild colitis and blocked by inhibition of transient receptor potential ankyrin 1 channels. Br J Pharmacol 160: 1430-1442.
37. Möller C, Sommer W, Thorsell A, Rimondini R, Heilig M, (2002). Anxiogenic-like action of centrally administered glucagon-like peptide-1 in a punished drinking test. Prog Neuropsychopharmacol Biol Psychiatry 26: 119-122. (Pubitemid 34045157)
38. Morales-Medina JC, Dumont Y, Quirion R, (2010). A possible role of neuropeptide Y in depression and stress. Brain Res 1314: 194-205.
39. Painsipp E, Wultsch T, Shahbazian A, Edelsbrunner M, Kreissl MC, Schirbel A, et al,. (2007). Experimental gastritis in mice enhances anxiety in a gender-related manner. Neuroscience 150: 522-536. (Pubitemid 350198722)
40. Painsipp E, Wultsch T, Edelsbrunner ME, Tasan RO, Singewald N, Herzog H, et al,. (2008). Reduced anxiety-like and depression-related behavior in neuropeptide Y Y4 receptor knockout mice. Genes Brain Behav 7: 532-542. (Pubitemid 351991488)
41. Pang XH, Li TK, Xie Q, He FQ, Cui DJ, Chen YQ, et al,. (2010). Amelioration of dextran sulfate sodium-induced colitis by neuropeptide Y antisense oligodeoxynucleotide. Int J Colorectal Dis 25: 1047-1053.
42. Redrobe JP, Dumont Y, Herzog H, Quirion R, (2003). Neuropeptide Y (NPY) Y2 receptors mediate behaviour in two animal models of anxiety: evidence from Y2 receptor knockout mice. Behav Brain Res 141: 251-255. (Pubitemid 36542973)
43. Redrobe JP, Carvajal C, Kask A, Dumont Y, Quirion R, (2004). Neuropeptide Y and its receptor subtypes in the central nervous system: emphasis on their role in animal models of psychiatric disorders. Handb Exp Pharmacol 162: 101-136.
44. Sah R, Ekhator NN, Strawn JR, Sallee FR, Baker DG, Horn PS, et al,. (2009). Low cerebrospinal fluid neuropeptide Y concentrations in posttraumatic stress disorder. Biol Psychiatry 66: 705-707.
45. Schmidt PT, Ljung T, Hartmann B, Hare KJ, Holst JJ, Hellström PM, (2005). Tissue levels and post-prandial secretion of the intestinal growth factor, glucagon-like peptide-2, in controls and inflammatory bowel disease: comparison with peptide YY. Eur J Gastroenterol Hepatol 17: 207-712.
46. Straub RH, Herfarth H, Falk W, Andus T, Schölmerich J, (2002). Uncoupling of the sympathetic nervous system and the hypothalamic-pituitary- adrenal axis in inflammatory bowel disease? J Neuroimmunol 126: 116-125. (Pubitemid 34521737)
47. Tari A, Teshima H, Sumii K, Haruma K, Ohgoshi H, Yoshihara M, et al,. (1988). Peptide YY abnormalities in patients with ulcerative colitis. Jpn J Med 27: 49-55.
48. Tasan RO, Lin S, Hetzenauer A, Singewald N, Herzog H, Sperk G, (2009). Increased novelty-induced motor activity and reduced depression-like behavior in neuropeptide Y (NPY)-Y4 receptor knockout mice. Neuroscience 158: 1717-1730.
49. Tasan RO, Nguyen NK, Weger S, Sartori SB, Singewald N, Heilbronn R, et al,. (2010). The central and basolateral amygdala are critical sites of neuropeptide Y/Y2 receptor-mediated regulation of anxiety and depression. J Neurosci 30: 6282-6290.
50. Tschenett A, Singewald N, Carli M, Balducci C, Salchner P, Vezzani A, et al,. (2003). Reduced anxiety and improved stress coping ability in mice lacking NPY-Y2 receptors. Eur J Neurosci 18: 143-148. (Pubitemid 36920855)
51. Ueno H, Yamaguchi H, Mizuta M, Nakazato M, (2008). The role of PYY in feeding regulation. Regul Pept 145: 12-16.
52. Wultsch T, Painsipp E, Thoeringer CK, Herzog H, Sperk G, Holzer P, (2005). Endogenous neuropeptide Y depresses the afferent signaling of gastric acid challenge to the mouse brainstem via neuropeptide Y type Y2 and Y4 receptors. Neuroscience 136: 1097-1107. (Pubitemid 41790523)
53. Zhou Z, Zhu G, Hariri AR, Enoch M, Scott D, Sinha R, et al,. (2008). Genetic variation in human NPY expression affects stress response and emotion. Nature 452: 997-1001. (Pubitemid 351589618)